Mesenchymal Stem Cells: A Good Candidate for Restenosis Therapy?
Journal:
Current Vascular Pharmacology
Volume:
7
Page:
381-393
Author(s):
Amalia Forte, Umberto Galderisi, Marilena Cipollaro and Antonino Cascino
The Role of Anaphylatoxins C3a and C5a in Regulating Innate and Adaptive Immune Responses
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
8
Page:
236-246
Author(s):
Qi Peng, Ke Li, Steven H. Sacks and Wuding Zhou
Successfully Resuscitated Sudden Cardiac Death in a Young Homosexual Male with HIV Myocarditis
Journal:
Current HIV Research
Volume:
7
Page:
434-436
Author(s):
Jan Belohlavek, Petr Kuchynka, Ladislav Machala, Vladimir Dytrych, Ivana Vitkova, Jana Schramlova, Ondrej Smid, Jana Gandalovicova and Ales Linhart
Recent Studies on Neural Tube Defects in Embryos of Diabetic Pregnancy: An Overview
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
2345-2354
Author(s):
S. Thameem Dheen, Samuel S.W. Tay, Jiang Boran, Loh Wan Ting, S. Dinesh Kumar, Jiang Fu and Eng-Ang Ling
Inhibition of Sphingomyelin Hydrolysis: Targeting the Lipid Mediator Ceramide as a Key Regulator of Cellular Fate
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
1978-2000
Author(s):
Ralf A. Claus, Michael J. Dorer, Alexander C. Bunck and H. Peter Deigner
Red Cell Glycolytic Enzyme Disorders Caused by Mutations: An Update
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
9
Page:
95-106
Author(s):
Fernando Climent, Feliu Roset, Ada Repiso and Pablo Perez de la Ossa
Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Journal:
Current Genomics
Volume:
10
Page:
281-293
Author(s):
E. Kirches
Function and Expression Pattern of Nonsyndromic Deafness Genes
Journal:
Current Molecular Medicine
Volume:
9
Page:
546-564
Author(s):
Nele Hilgert, Richard J.H. Smith and Guy Van Camp
Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Journal:
Current Drug Metabolism
Volume:
10
Page:
470-481
Author(s):
Jorg Thomas Hartmann, Michael Haap, Hans-Georg Kopp and Hans-Peter Lipp
Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
151-177
Author(s):
S. Rutella, G. Bonanno and R. De Cristofaro